Novo Nordisk CEO agrees to appear at a Senate hearing to defend the ... had requested that Jørgensen not be the only industry representative in the GLP-1 agonist market to testify at the ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake of "market challenges".

Novo Nordisk, maker of weight loss drug Wegovy, ... Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down. Updated on: May 16, 2025 / 10:09 AM EDT / AP ...

Novo Nordisk said Friday that CEO Lars Fruergaard Jørgensen is stepping down as the Wegovy maker seeks to revive its ailing fortunes amid increasing competition. Stream Los Angeles News for free ...

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down. The Danish company is citing a steep decline in the company’s share price.

Lars Fruergaard Jørgensen, CEO of Novo Nordisk, to step down as company seeks a turnaround. Company found success with Wegovy and Ozempic, but share price has fallen by half in past year.

Ozempic maker Novo Nordisk NOVO.B-0.99%decrease; red down pointing triangle pushed out its chief executive after losing ground in the anti-obesity drug market, which has caused a steep stock-price ...

Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down, the Wegovy-maker said Friday, citing recent market challenges. The Danish pharmaceutical giant said Fruergaard Jørgensen would remain ...

Reuters. FILE PHOTO: CEO of Novo Nordisk Lars Fruergaard Jorgensen is seen during the 6th edition of the "Choose France" Summit at the Chateau de Versailles, outside Paris on May 15, 2023.

Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down as the Danish drug giant faces increased competition for its weight-loss drugs and declining share price. Why it matters: Novo has ...

“During his eight-year tenure as CEO, Novo Nordisk’s sales, profits and share price have almost tripled,” Novo Nordisk said. The 58-year-old Danish executive has spent his entire career at ...

As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, ... Policy & Regulation category US energy firm EQT agrees to settle lawsuit for $167.5 million. June 27, 2025.